Area of research
Oncology · Cancer Research
Research interest
Research interests include Medicine, Internal medicine, Clinical endpoint, Apatinib, Metastatic breast cancer, and Breast cancer.
Evaluating the efficacy of fruquintinib versus regorafenib and trifluridine/tipiracil in treating advanced metastatic colorectal cancer: A match-adjusted indirect comparison.
A randomized, double-blind, placebo-controlled, multi-centered phase 3 trial comparing fruquintinib versus placebo plus best supportive care in Chinese patients with metastatic colorectal cancer (FRESCO).
B7-H3 expression associates with tumor invasion and patient's poor survival in human esophageal cancer.
PubMed 2015cited by 62position: middle
Multicenter phase II study of Apatinib in non-triple-negative metastatic breast cancer
Multicenter randomized double-blind controlled phase III study of hhpg-19K as prophylactic therapy in patients with advanced non-small cell lung cancer (NSCLC) receiving myelosuppressive chemotherapy.
Gemcitabine with Cisplatin or Paclitaxel in Metastatic Triple-Negative Breast Cancer